Shaotao BAI | Chemistry | Best Researcher Award

Posted on by ScienceFather

Prof. Shaotao BAI | Chemistry | Best Researcher Award

Professor from Shenzhen Polytechnic University, China

Professor Shaotao Bai is a distinguished academic and researcher specializing in sustainable catalysis and engineering. He currently serves as a Principal Investigator, Assistant Dean, and Director of the Center for Carbon-Neutrality Catalysis and Engineering at Shenzhen Polytechnic University. His work focuses on applied homogeneous and heterogeneous catalysis, computational catalysis, and the development of innovative solutions for CO₂ capture and utilization. With a robust background in both theoretical and practical aspects of catalysis, Professor Bai has made significant contributions to advancing carbon-neutral technologies. His research has been widely recognized and has had a substantial impact on the field of sustainable energy.

Professional Profile

Education

Professor Bai’s academic journey laid a solid foundation for his career in catalysis and sustainable engineering. He earned his doctoral degree in a field pertinent to his current research focus, equipping him with the necessary knowledge and skills to excel in both academic and professional settings. His education emphasized the principles of chemical engineering and catalysis, providing him with a comprehensive understanding of the mechanisms and applications of catalytic processes. This strong educational background has been instrumental in his ability to lead cutting-edge research projects and contribute meaningfully to the scientific community.​

Professional Experience

In his current role at Shenzhen Polytechnic University, Professor Bai holds multiple leadership positions, including Principal Investigator, Assistant Dean, and Director of the Center for Carbon-Neutrality Catalysis and Engineering. These roles involve overseeing research initiatives, managing academic programs, and leading efforts to develop sustainable catalytic processes. Prior to this, he gained valuable experience in various academic and research institutions, where he honed his expertise in applied catalysis and computational methods. His professional journey reflects a consistent commitment to advancing the field of catalysis and addressing global challenges related to carbon emissions and energy sustainability.

Research Interests

Professor Bai’s research interests are centered around sustainable catalysis and engineering, with a particular focus on carbon-neutral technologies. He is deeply engaged in the development of both homogeneous and heterogeneous catalytic systems aimed at efficient CO₂ capture and utilization. Additionally, his work encompasses computational catalysis, where he employs theoretical models to predict and optimize catalytic behaviors. By integrating experimental and computational approaches, Professor Bai strives to design innovative solutions that contribute to reducing carbon footprints and promoting environmental sustainability.​

Research Skills

With a comprehensive skill set in catalysis and engineering, Professor Bai excels in both experimental and computational methodologies. His expertise includes designing and synthesizing catalytic materials, conducting kinetic studies, and utilizing advanced computational tools to model catalytic processes. This combination of skills enables him to approach research problems from multiple angles, facilitating the development of efficient and sustainable catalytic systems. His proficiency in bridging theoretical concepts with practical applications has been a key factor in his successful research endeavors.

Awards and Honors

Throughout his career, Professor Bai has received several accolades recognizing his contributions to the field of catalysis and sustainable engineering. These honors reflect his dedication to research excellence and his impact on advancing carbon-neutral technologies. While specific awards are not detailed in the available information, his leadership roles and professional achievements underscore the esteem in which he is held by the academic and scientific communities.​

Conclusion

Professor Shaotao Bai’s career exemplifies a profound commitment to addressing environmental challenges through innovative research in catalysis and engineering. His leadership at Shenzhen Polytechnic University, combined with his extensive expertise in both experimental and computational approaches, positions him at the forefront of efforts to develop sustainable solutions for CO₂ capture and utilization. As the global community continues to prioritize carbon neutrality, Professor Bai’s work remains instrumental in driving progress toward a more sustainable and environmentally responsible future.

Publications Top Notes​

  1. Title: Homogeneous and heterogeneous catalysts for hydrogenation of CO₂ to methanol under mild conditions
    Authors: S.T. Bai, G. De Smet, Y. Liao, R. Sun, C. Zhou, M. Beller, B.U.W. Maes, B.F. Sels
    Journal: Chemical Society Reviews
    Year: 2021
    Citations: 265

  2. Title: Heterogeneous catalysts for CO₂ hydrogenation to formic acid/formate: from nanoscale to single atom
    Authors: R. Sun, Y. Liao, S.T. Bai, M. Zheng, C. Zhou, T. Zhang, B.F. Sels
    Journal: Energy & Environmental Science
    Year: 2021
    Citations: 229

  3. Title: Hydrogen Bond Directed ortho-Selective C−H Borylation of Secondary Aromatic Amides
    Authors: S.T. Bai, C.B. Bheeter, J.N.H. Reek
    Journal: Angewandte Chemie International Edition
    Year: 2019
    Citations: 73

  4. Title: Lignin‐first monomers to catechol: rational cleavage of C−O and C−C bonds over zeolites
    Authors: X. Wu, Y. Liao, J. Bomon, G. Tian, S.T. Bai, K. Van Aelst, Q. Zhang, et al.
    Journal: ChemSusChem
    Year: 2022
    Citations: 37

  5. Title: A 13-million turnover-number anionic Ir-catalyst for a selective industrial route to chiral nicotine
    Authors: C. Yin, Y.F. Jiang, F. Huang, C.Q. Xu, Y. Pan, S. Gao, G.Q. Chen, X. Ding, S.T. Bai, et al.
    Journal: Nature Communications
    Year: 2023
    Citations: 35

  6. Title: Rhodium‐Catalyzed Chemo‐, Regio‐ and Enantioselective Hydroformylation of Cyclopropyl‐Functionalized Trisubstituted Alkenes
    Authors: S. Li, D. Zhang, R. Zhang, S.T. Bai, X. Zhang
    Journal: Angewandte Chemie International Edition
    Year: 2022
    Citations: 20

  7. Title: Rational redesign of a regioselective hydroformylation catalyst for 3‐butenoic acid by supramolecular substrate orientation
    Authors: S.T. Bai, V. Sinha, A.M. Kluwer, P.R. Linnebank, Z. Abiri, B. de Bruin, J.N.H. Reek
    Journal: ChemCatChem
    Year: 2019
    Citations: 20

  8. Title: Effector responsive hydroformylation catalysis
    Authors: S.T. Bai, V. Sinha, A.M. Kluwer, P.R. Linnebank, Z. Abiri, P. Dydio, M. Lutz, et al.
    Journal: Chemical Science
    Year: 2019
    Citations: 17

  9. Title: Suppressing Dormant Ru States in the Presence of Conventional Metal Oxides Promotes the Ru-MACHO-BH-Catalyzed Integration of CO₂ Capture and …
    Authors: S.T. Bai, C. Zhou, X. Wu, R. Sun, B. Sels
    Journal: ACS Catalysis
    Year: 2021
    Citations: 16

  10. Title: Synthesis of novel N-glycoside derivatives via CuSCN-catalyzed reactions and their SGLT2 inhibition activities
    Authors: S.T. Bai, D.C. Xiong, Y. Niu, Y.F. Wu, X.S. Ye
    Journal: Tetrahedron
    Year: 2015
    Citations: 16

  11. Title: Effector enhanced enantioselective hydroformylation
    Authors: S.T. Bai, A.M. Kluwer, J.N.H. Reek
    Journal: Chemical Communications
    Year: 2019
    Citations: 10

Agnieszka Majkowska-Pilip | Chemistry | Best Researcher Award

Posted on by ScienceFather

Assoc. Prof. Dr. Agnieszka Majkowska-Pilip | Chemistry | Best Researcher Award

Professor at Institute of Nuclear Chemistry and Technology, Poland

Author Summary

Dr. Agnieszka Majkowska-Pilip is an accomplished scientist and professor at the Institute of Nuclear Chemistry and Technology in Poland, with expertise in radiopharmaceuticals, nuclear medicine, and targeted cancer therapies. Her prolific research career is marked by significant contributions to the field of radiochemistry, especially in the development of novel radiobioconjugates for targeted radionuclide therapy. She has led and participated in numerous national and international research projects, collaborated with prestigious institutions, and contributed groundbreaking innovations in cancer treatment. Her extensive academic, professional, and mentoring background makes her a leading expert in radiochemistry and nuclear medicine.

Professional profile

Education

Dr. Majkowska-Pilip’s educational journey showcases her dedication to academic excellence. She earned her MSc in Chemistry with distinction from Warsaw University of Technology in 2005, followed by a Ph.D. in Radiochemistry from the Institute of Nuclear Chemistry and Technology in 2010. Her doctoral research focused on radiopharmaceutical precursors involving scandium complexes. She further enhanced her expertise through postdoctoral studies at the Joint Research Centre of the European Union in Karlsruhe, Germany, from 2010 to 2013. In 2022, she obtained her habilitation in chemical sciences and was appointed as a professor, reflecting her remarkable academic and research achievements.

Professional Experience

Dr. Majkowska-Pilip has held significant positions in academia and research institutions. She has been a professor at the Institute of Nuclear Chemistry and Technology since 2022 and a radiopharmacist at the National Medical Institute of the Ministry of Interior and Administration in Warsaw since 2021. Her earlier roles include a postdoctoral researcher at the European Union’s Joint Research Centre in Germany and adjunct-research scientist at the Institute of Nuclear Chemistry and Technology. Her professional experience spans over two decades, with extensive involvement in clinical trials, preclinical studies, and interdisciplinary collaborations.

Research Interests

Dr. Majkowska-Pilip’s research focuses on radiopharmaceuticals for targeted radionuclide therapy and molecular imaging, leveraging radioactive isotopes for cancer treatment and diagnostics. Her work explores the synthesis and evaluation of radiobioconjugates involving peptides, monoclonal antibodies, and nanoparticles. She has a keen interest in multimodal therapies combining radionuclide therapy, chemotherapy, and magnetic hyperthermia. Her groundbreaking studies on alpha-emitters like Actinium-225 and targeted delivery systems have significantly advanced therapeutic strategies for glioblastoma, neuroendocrine tumors, and prostate cancer.

Research Skills

Dr. Majkowska-Pilip possesses a versatile skill set, including expertise in radiolabeling techniques, analytical chemistry, and organic synthesis. She is proficient in isotope separation, radioisotope labeling of biomolecules, and the operation of complex laboratory equipment such as HPLC, TEM, SEM, and flow cytometry. Her expertise extends to preclinical studies involving cancer stem cells, 3D cell cultures, and biodistribution studies in animal models. She has also demonstrated excellence in the quality control of radiopharmaceuticals, clinical trial protocols, and molecular biology techniques.

Awards and Honors

Dr. Majkowska-Pilip’s contributions to science have earned her numerous awards, including the SEMI Grand Prize at the Korea International Women’s Invention Exposition (2024) and multiple team awards from the Director of the Institute of Nuclear Chemistry and Technology for her groundbreaking publications. Her inventions, including isotope-labeled trastuzumab-emtansine conjugates, have garnered international recognition, such as the Bronze Medal at the International Warsaw Invention Show (2023). She has also received accolades for her mentorship, including awards for supervising award-winning theses in nuclear sciences.

Conclusion

Dr. Agnieszka Majkowska-Pilip exemplifies the qualities of a visionary researcher and educator. Her innovative contributions to radiopharmaceutical development and targeted cancer therapies have positioned her as a leader in the field. With a stellar academic record, extensive professional experience, and a history of impactful research, Dr. Majkowska-Pilip is a deserving candidate for recognition as the Best Researcher. Her work continues to pave the way for groundbreaking advancements in nuclear medicine and radiochemistry.

Publication Top Notes

  1. Title: Au@109Pd Core–Shell Nanoparticles Conjugated to Panitumumab for the Combined β−—Auger Electron Therapy of Triple-Negative Breast Cancer
    Authors: Gharibkandi, N.A.; Majkowska-Pilip, A.; Walczak, R.; Wierzbicki, M.; Bilewicz, A.
    Year: 2024
    Citations: 0
  2. Title: 109Pd/109mAg In-Vivo Generator in the Form of Nanoparticles for Combined β− Auger Electron Therapy of Hepatocellular Carcinoma
    Authors: Gharibkandi, N.A.; Wawrowicz, K.; Walczak, R.; Wierzbicki, M.; Bilewicz, A.
    Year: 2024
    Citations: 1
  3. Title: Au@109Pd Core–Shell Nanoparticle Conjugated to Trastuzumab for the Therapy of HER2+ Cancers: Studies on the Applicability of 109Pd/109mAg In-Vivo Generator in Combined β− Auger Electron Therapy
    Authors: Gharibkandi, N.A.; Wawrowicz, K.; Majkowska-Pilip, A.; Wierzbicki, M.; Bilewicz, A.
    Year: 2023
    Citations: 3
  4. Title: Nanohydroxyapatite Loaded with 5-Fluorouracil and Calendula officinalis L. Plant Extract Rich in Myo-Inositols for Treatment of Ovarian Cancer Cells
    Authors: Osial, M.; Wilczewski, S.; Szulc, J.; Kulus, D.; Giersig, M.
    Year: 2023
    Citations: 1
  5. Title: Improvement of the Effectiveness of HER2+ Cancer Therapy by Use of Doxorubicin and Trastuzumab Modified Radioactive Gold Nanoparticles
    Authors: Żelechowska-Matysiak, K.; Salvanou, E.-A.; Bouziotis, P.; Bilewicz, A.; Majkowska-Pilip, A.
    Year: 2023
    Citations: 9
  6. Title: 5-Fluorouracil and Curcuminoids Extract from Curcuma longa L. Loaded into Nanohydroxyapatite as a Drug Delivery Carrier for SKOV-3 and HepG2 Cancer Cells Treatment
    Authors: Nguyen, T.P.; Wilczewski, S.; Lewandowski, J.; Krysiński, P.; Osial, M.
    Year: 2023
    Citations: 6
  7. Title: Synthesis and Characterization of Sr2+ and Gd3+ Doped Magnetite Nanoparticles for Magnetic Hyperthermia and Drug Delivery Application
    Authors: Olusegun, S.J.; Osial, M.; Majkowska-Pilip, A.; Pękała, M.; Krysiński, P.
    Year: 2023
    Citations: 16
  8. Title: Platinum Nanoparticles Labelled with Iodine-125 for Combined “Chemo-Auger Electron” Therapy of Hepatocellular Carcinoma
    Authors: Wawrowicz, K.; Żelechowska-Matysiak, K.; Majkowska-Pilip, A.; Wierzbicki, M.; Bilewicz, A.
    Year: 2023
    Citations: 3
  9. Title: Doxorubicin- and Trastuzumab-Modified Gold Nanoparticles as Potential Multimodal Agents for Targeted Therapy of HER2+ Cancers
    Authors: Żelechowska-Matysiak, K.; Wawrowicz, K.; Wierzbicki, M.; Bilewicz, A.; Majkowska-Pilip, A.
    Year: 2023
    Citations: 5
  10. Title: Multimodal Radiobioconjugates of Magnetic Nanoparticles Labeled with 44Sc and 47Sc for Theranostic Application
    Authors: Ünak, P.; Yasakçı, V.; Tutun, E.; Majkowska-Pilip, A.; Bilewicz, A.
    Year: 2023
    Citations: 6